NASDAQ:ARMO Investor Alert: Investigation over Possible Wrongdoing in Acquisition of ARMO BioSciences, Inc
An investigation was announced for investors, who currently hold shares of ARMO BioSciences, Inc. (NASDAQ: ARMO),over the takeover of ARMO BioSciences, Inc. by Eli Lilly and Company for $50.00 per share is unfair to NASDAQ: ARMO stockholders.
View full press release